SEER Seer Inc
- 2.150
- +0.030+1.42%
Seer Inc News
Seer to Report First Quarter 2024 Financial Results on May 8, 2024
REDWOOD CITY, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it
Seer, Inc. (NASDAQ:SEER) Is a Favorite Amongst Institutional Investors Who Own 51%
Candel Therapeutics Receives FDA Orphan Drug Designation for Its Pancreatic Cancer Treatment
Seer Inc(SEER.US) Officer Sells US$107.42K in Common Stocks
$Seer Inc(SEER.US)$ Officer Farokhzad Omid sold 52,857 shares of Common Stocks on Mar 7, 2024 at an average price of $2.0323 for a total value of $107.42K.Source: Announcement What is statement of cha
Seer Price Target Announced at $7.00/Share by Morgan Stanley
Seer Price Target Announced at $7.00/Share by Morgan Stanley
Morgan Stanley Reinstates Equal-Weight on Seer, Announces $7 Price Target
Morgan Stanley analyst Yuko Oku reinstates Seer with a Equal-Weight and announces $7 price target.
Seer Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/05/2024 257.14% Morgan Stanley → $7 Reinstates → Equal-Weight 02/21/2023 410.2% Morgan Stanley $11 → $1
Seer, Inc. (NASDAQ:SEER) Just Reported, And Analysts Assigned A US$7.00 Price Target
Earnings Call Summary | Seer Inc(SEER.US) Q4 2023 Earnings Conference
The following is a summary of the Seer, Inc. (SEER) Q4 2023 Earnings Call Transcript:Financial Performance:Seer reported a Q4 2023 revenue of $4.4 million, a 4% decrease from Q4 2022, primarily due to
Seer Sees FY24 Revenue $18M-$20M Vs $19.801M Est.
Seer Sees FY24 Revenue $18M-$20M Vs $19.801M Est.
Seer GAAP EPS of -$0.28 Beats by $0.10, Revenue of $4.4M Beats by $0.35M
Earnings Flash (SEER) SEER Reports Q4 Revenue $4.4M, Vs. Street Est of $4.05M
04:05 PM EST, 02/29/2024 (MT Newswires) -- Earnings Flash (SEER) SEER Reports Q4 Revenue $4.4M, vs. Street Est of $4.05M
Press Release: Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer data
Earnings Scheduled For February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million. • NB Bancorp (NASDAQ:NBBK) is likely to report ear
Seer Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Outlook
Enhanced access to the Proteograph Product Suite and demonstrated its power with new customer dataREDWOOD CITY, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sc
Seer Q4 2023 Earnings Preview
Seer Inc(SEER.US) Officer Sells US$20,024.23 in Common Stocks
$Seer Inc(SEER.US)$ Officer Horn David R. sold 12,684 shares of Common Stocks on Feb 22, 2024 at an average price of $1.5787 for a total value of $20,024.23. This transaction involves other related pa
This Seer Insider Increased Their Holding By 19% Last Year
Seer to Participate in the TD Cowen 44th Annual Health Care Conference
REDWOOD CITY, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the
Zoom Video And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed higher by around 1% on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their
Analysis
Price Target
No Data
